Hugo Cheinquer
机构: Professor of Medicine, Universidade Federal do Rio Grande do Sul
每年引用次数
引用次数
引用: 8,982
H-指数: 32
I10-指数 : 57
出版物: 226
562 Prospective randomized study of peginterferon alpha-2a, ribavirin and amantadine vs peginterferon alpha-2a plus ribavirin, in hepatitis C patients now responders or relapsers to interferon-alpha and ribavirin
H. Cheinguer , M. Pessoa , P. Almeida , G. Silva
Journal of Hepatology 44
2
2006
Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis.
Angelo Alves De Mattos , Hugo Cheinquer , Daniel Maffasioli Goncaves , Maicon Becker
Hepato-gastroenterology 50 ( 54) 2052 -2056
8
2003
Guía Latinoamericana de Manejo de la Hepatitis Crónica B
Cristina Galoppo , Gilda Porta , Miguel Garassini , Jorge Ferrandiz
Acta gastroenterologica Latinoamericana 41 ( 4) 340 -350
2
2011
Guía Latinoamericana de Tratamiento de la Hepatitis Crónica B
Jorge Daruich , Adrián Gadano , Hugo Fainboim , Mario Pessoa
Acta gastroenterologica Latinoamericana 37 ( 3) 168 -177
14
2007
HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload
Luciano Krug , Nelson Cheinquer , Patrícia Ashton-Prolla , Silvia Coelho-Borges
The American Journal of Gastroenterology 97 ( 6) 1570 -1572
8
2002
Doenca hepatica cronica pelo virus c : relacao entre quantificacao viral, aspectos demograficos, laboratoriais e histopatologicos
Hugo Cheinquer
1996
1990
Preliminary results from TOPAZ-III, a phase 3b study evaluating the efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in naive or experienced adults in Brazil with HCV genotype 1 infection and advanced fibrosis/cirrhosis
Mario G Pessoa , José Valdez Madruga Ramalho , Katia Alves , Daniel E Cohen
Hepatology 64
2016
Transient elastography in HIV infected patients with liver steatosis identifies a high risk group for non-alcoholic steatohepatitis.
Eduardo Sprinz , Julia Poeta , Alexandre de Araujo , Hugo Cheinquer
Current HIV Research 19
2021
'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant.
Fabrizio Fabrizi , Margarita Anders , Ezequiel Ridruejo , Cristina Alonso
Annals of Hepatology 25 100337 -100337
1
2021
Mecanismos de açäo dos interferons: uma revisäo
Nelson Cheinquer , Silvia Coelho Borges , Hugo Cheinquer
Rev. AMRIGS
1997
A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa‐2a (40kD)/ribavirin
Peter Ferenci , Rodrigo Aires , Ioan Ancuta , Andrew Arohnson
Liver International 34 ( 10) 1550 -1559
6
2014
Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.
Federico Piñero , Manuel Mendizabal , Ezequiel Ridruejo , Fernando Herz Wolff
Liver International 39 ( 6) 1033 -1043
28
2019
Intranasal cocaine use does not appear to be an independent risk factor for HCV infection.
Bruno Galperim , Hugo Cheinquer , Airton Stein , André Fonseca
Addiction 99 ( 8) 973 -977
20
2004
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
Daniel Shouval , Ching-Lung Lai , Ting-Tsung Chang , Hugo Cheinquer
Journal of Hepatology 50 ( 2) 289 -295
95
2009
Induction Pegylated Interferon Alfa-2a and High Dose Ribavirin Do Not Increase SVR in Heavy Patients With HCV Genotype 1 and High Viral Loads
K Rajender Reddy , Mitchell L Shiffman , Maribel Rodriguez–Torres , Hugo Cheinquer
Gastroenterology 139 ( 6) 1972 -1983
30
2010
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach , Stefan Zeuzem , Michael Manns , Ibrahim Altraif
The Lancet Gastroenterology & Hepatology 2 ( 3) 161 -176
1,821
2017
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
Graham S Cooke , Isabelle Andrieux-Meyer , Tanya L Applegate , Rifat Atun
The Lancet Gastroenterology & Hepatology 4 ( 2) 135 -184
376
2019
52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B
Teerha Piratvisuth , Piyawat Komolmit , Tawesak Tanwandee , Wattana Sukeepaisarnjaroen
PLoS ONE 8 ( 2) e54279
32
2013
Bosentan Inducing Autoimmune Hepatitis in a Patient with Idiopathic Pulmonary Arterial Hypertension.
Alexandre De Araujo , Augusto Mantovani , Carlos Thadeu Schmidt Cerski , Antonio Barros Lopes
Journal of Gastrointestinal and Liver Diseases 27 ( 1) 89 -92
2018